Late trading session sees stock gain 13.8% to trade at $3.28 per share

  • Annexon shares rise 13% after pricing underwritten public offering
  • Late trading session sees stock gain 13.8% to trade at $3.28 per share
  • Annexon plans to offer 25,035,000 shares of common stock at $2.88 per share
  • Pre-funded warrants to purchase 18,379,861 shares of common stock also offered

Shares of Annexon were higher in the late trading session after the biopharmaceutical company priced a $125 million underwritten public offering of stock and warrants. The stock had gained 13.8% to trade at $3.28 per share. Annexon said it planned to offer 25,035,000 shares of common stock at $2.88 per share, along with pre-funded warrants to purchase 18,379,861 shares of common stock.

Public Companies: Annexon (Inc.)
Private Companies:
Key People:

Track all markets on TradingView

Factuality Level: 8
Justification: The article provides factual information about the pricing of a public offering of stock and warrants by Annexon. The information is specific and does not contain any irrelevant or misleading details. However, it lacks additional context or analysis, which prevents it from being a 10 in factuality.

Noise Level: 3
Justification: The article provides information about the pricing of a public offering of stock and warrants by Annexon. However, it lacks analysis, evidence, and actionable insights. It is mostly focused on reporting the stock price movements and the details of the offering, without providing any meaningful context or implications.

Financial Relevance: Yes
Financial Markets Impacted: Shares of Inc. Annexon

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The news article pertains to a financial topic as it discusses the pricing of a $125 million underwritten public offering of stock and warrants by biopharmaceutical company Inc. Annexon. There is no mention of an extreme event or its impact in the article.

Reported publicly: www.marketwatch.com